Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
The symposium is proposed to make awareness in the academic research community on how to achieve successful translation of research results. The seminar & workshop will bring together Key Industrial Players, End-Users, Entrepreneurs, Investors, Top-class Scientists, Engineers, Policy Makers and Representatives from the UK, European and International Authorities to discuss, network and establish the Strategy and Policy for boosting the rapidly evolving nanomedicine Industry. Nanomedicine revolutionizes applications in cancer diagnosis, smart therapy, Health Care. This symposium will focus on 1) Clinical nanomedicine current stage and future. 2) Industrial Translation 3) IPR, Patent and technology transfers.
Speakers:
1. Prof. Ali Khademhosseini, Chief Executive officer Terasaki Institute (Amazon Professor at Harvard Medical School (2005-2017). The Highly Cited Researcher in the field of Nanomedicine
2. Prof. Y. Shrike Zhang, Harvard Medical School, Brigham and Women’s Hospital, University of Harvard
3. Prof. Twan Lammers, Professor of Medicine, RWTH Aachen University, Germany, The Highly Cited Researcher in the field of Industrial Nanomedicine
4. Prof. Helen Townley, Medical Science Division, University of Oxford, Oxford UK
5. Dr. Tanveer Tabish, Radcliffe Department of Medicine, University of Oxford, Oxford UK, Fellow of the British Heart Foundation.
6. Dr. David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada at AstraZeneca
